 | • レポートコード：MRC2012B0126 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオ医薬品受託製造の世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオ医薬品受託製造の種類別市場規模（成長因子、インターフェロン、モノクローナル抗体、組換えホルモン、ワクチン、インスリン、その他）、用途別市場規模（自己免疫疾患、腫瘍学、代謝性疾患、眼科、心血管疾患、感染症、神経学、呼吸器疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Lonza Group、Biomeva、Fujifilm Diosynth Biotechnologies、Baxter Biopharma Solutions、Rentschler Biotechnologie、Samsung、Cytovance Biologics、Patheon、Boehringer Ingelheim、Probiogen、KBI Biopharma、WuXi Biologics、Abzena、 ・地域別グローバル市場分析 2015年-2020年 ・バイオ医薬品受託製造の北米市場（アメリカ、カナダ、メキシコ） ・バイオ医薬品受託製造のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオ医薬品受託製造のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオ医薬品受託製造の南米市場（ブラジル、アルゼンチン） ・バイオ医薬品受託製造の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：成長因子、インターフェロン、モノクローナル抗体、組換えホルモン、ワクチン、インスリン、その他 ・用途別分析：自己免疫疾患、腫瘍学、代謝性疾患、眼科、心血管疾患、感染症、神経学、呼吸器疾患、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Biopharmaceutical Contract Manufacturing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Biopharmaceutical Contract Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biopharmaceutical Contract Manufacturing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biopharmaceutical Contract Manufacturing market has been segmented into:
Growth Factors
Interferons
Monoclonal Antibodies
Recombinant Hormones
Vaccines
Insulin
Others
By Application, Biopharmaceutical Contract Manufacturing has been segmented into:
Autoimmune Diseases
Oncology
Metabolic Diseases
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Neurology
Respiratory Disorders
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biopharmaceutical Contract Manufacturing market presented in the report. This section sheds light on the sales growth of different regional and country-level Biopharmaceutical Contract Manufacturing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biopharmaceutical Contract Manufacturing market.
The report offers in-depth assessment of the growth and other aspects of the Biopharmaceutical Contract Manufacturing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biopharmaceutical Contract Manufacturing Market Share Analysis
Biopharmaceutical Contract Manufacturing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biopharmaceutical Contract Manufacturing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biopharmaceutical Contract Manufacturing sales, revenue and market share for each player covered in this report.
The major players covered in Biopharmaceutical Contract Manufacturing are:
Lonza Group
Biomeva
Fujifilm Diosynth Biotechnologies
Baxter Biopharma Solutions
Rentschler Biotechnologie
Samsung
Cytovance Biologics
Patheon
Boehringer Ingelheim
Probiogen
KBI Biopharma
WuXi Biologics
Abzena
Table of Contents
1 Biopharmaceutical Contract Manufacturing Market Overview
1.1 Product Overview and Scope of Biopharmaceutical Contract Manufacturing
1.2 Classification of Biopharmaceutical Contract Manufacturing by Type
1.2.1 Global Biopharmaceutical Contract Manufacturing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type in 2019
1.2.3 Growth Factors
1.2.4 Interferons
1.2.5 Monoclonal Antibodies
1.2.6 Recombinant Hormones
1.2.7 Vaccines
1.2.8 Insulin
1.2.9 Others
1.3 Global Biopharmaceutical Contract Manufacturing Market by Application
1.3.1 Overview: Global Biopharmaceutical Contract Manufacturing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Metabolic Diseases
1.3.5 Ophthalmology
1.3.6 Cardiovascular Diseases
1.3.7 Infectious Diseases
1.3.8 Neurology
1.3.9 Respiratory Disorders
1.3.10 Others
1.4 Global Biopharmaceutical Contract Manufacturing Market by Regions
1.4.1 Global Biopharmaceutical Contract Manufacturing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biopharmaceutical Contract Manufacturing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biopharmaceutical Contract Manufacturing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical Contract Manufacturing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical Contract Manufacturing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biopharmaceutical Contract Manufacturing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical Contract Manufacturing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Lonza Group
2.1.1 Lonza Group Details
2.1.2 Lonza Group Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Lonza Group SWOT Analysis
2.1.4 Lonza Group Product and Services
2.1.5 Lonza Group Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biomeva
2.2.1 Biomeva Details
2.2.2 Biomeva Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biomeva SWOT Analysis
2.2.4 Biomeva Product and Services
2.2.5 Biomeva Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Fujifilm Diosynth Biotechnologies
2.3.1 Fujifilm Diosynth Biotechnologies Details
2.3.2 Fujifilm Diosynth Biotechnologies Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Fujifilm Diosynth Biotechnologies SWOT Analysis
2.3.4 Fujifilm Diosynth Biotechnologies Product and Services
2.3.5 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Baxter Biopharma Solutions
2.4.1 Baxter Biopharma Solutions Details
2.4.2 Baxter Biopharma Solutions Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Baxter Biopharma Solutions SWOT Analysis
2.4.4 Baxter Biopharma Solutions Product and Services
2.4.5 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Rentschler Biotechnologie
2.5.1 Rentschler Biotechnologie Details
2.5.2 Rentschler Biotechnologie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Rentschler Biotechnologie SWOT Analysis
2.5.4 Rentschler Biotechnologie Product and Services
2.5.5 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Samsung
2.6.1 Samsung Details
2.6.2 Samsung Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Samsung SWOT Analysis
2.6.4 Samsung Product and Services
2.6.5 Samsung Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cytovance Biologics
2.7.1 Cytovance Biologics Details
2.7.2 Cytovance Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cytovance Biologics SWOT Analysis
2.7.4 Cytovance Biologics Product and Services
2.7.5 Cytovance Biologics Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Patheon
2.8.1 Patheon Details
2.8.2 Patheon Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Patheon SWOT Analysis
2.8.4 Patheon Product and Services
2.8.5 Patheon Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Probiogen
2.10.1 Probiogen Details
2.10.2 Probiogen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Probiogen SWOT Analysis
2.10.4 Probiogen Product and Services
2.10.5 Probiogen Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.11 KBI Biopharma
2.11.1 KBI Biopharma Details
2.11.2 KBI Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 KBI Biopharma SWOT Analysis
2.11.4 KBI Biopharma Product and Services
2.11.5 KBI Biopharma Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.12 WuXi Biologics
2.12.1 WuXi Biologics Details
2.12.2 WuXi Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 WuXi Biologics SWOT Analysis
2.12.4 WuXi Biologics Product and Services
2.12.5 WuXi Biologics Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.13 Abzena
2.13.1 Abzena Details
2.13.2 Abzena Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Abzena SWOT Analysis
2.13.4 Abzena Product and Services
2.13.5 Abzena Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biopharmaceutical Contract Manufacturing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biopharmaceutical Contract Manufacturing Players Market Share
3.2.2 Top 10 Biopharmaceutical Contract Manufacturing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biopharmaceutical Contract Manufacturing Revenue and Market Share by Regions
4.2 North America Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
4.3 Europe Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
4.5 South America Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
5 North America Biopharmaceutical Contract Manufacturing Revenue by Countries
5.1 North America Biopharmaceutical Contract Manufacturing Revenue by Countries (2015-2020)
5.2 USA Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
5.3 Canada Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
5.4 Mexico Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
6 Europe Biopharmaceutical Contract Manufacturing Revenue by Countries
6.1 Europe Biopharmaceutical Contract Manufacturing Revenue by Countries (2015-2020)
6.2 Germany Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
6.3 UK Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
6.4 France Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
6.5 Russia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
6.6 Italy Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Countries
7.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Countries (2015-2020)
7.2 China Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
7.3 Japan Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
7.4 Korea Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
7.5 India Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
8 South America Biopharmaceutical Contract Manufacturing Revenue by Countries
8.1 South America Biopharmaceutical Contract Manufacturing Revenue by Countries (2015-2020)
8.2 Brazil Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
8.3 Argentina Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biopharmaceutical Contract Manufacturing by Countries
9.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
9.3 UAE Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
9.4 Egypt Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
9.5 South Africa Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biopharmaceutical Contract Manufacturing Revenue and Market Share by Type (2015-2020)
10.2 Global Biopharmaceutical Contract Manufacturing Market Forecast by Type (2019-2024)
10.3 Growth Factors Revenue Growth Rate (2015-2025)
10.4 Interferons Revenue Growth Rate (2015-2025)
10.5 Monoclonal Antibodies Revenue Growth Rate (2015-2025)
10.6 Recombinant Hormones Revenue Growth Rate (2015-2025)
10.7 Vaccines Revenue Growth Rate (2015-2025)
10.8 Insulin Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Biopharmaceutical Contract Manufacturing Market Segment by Application
11.1 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2015-2020)
11.2 Biopharmaceutical Contract Manufacturing Market Forecast by Application (2019-2024)
11.3 Autoimmune Diseases Revenue Growth (2015-2020)
11.4 Oncology Revenue Growth (2015-2020)
11.5 Metabolic Diseases Revenue Growth (2015-2020)
11.6 Ophthalmology Revenue Growth (2015-2020)
11.7 Cardiovascular Diseases Revenue Growth (2015-2020)
11.8 Infectious Diseases Revenue Growth (2015-2020)
11.9 Neurology Revenue Growth (2015-2020)
11.10 Respiratory Disorders Revenue Growth (2015-2020)
11.11 Others Revenue Growth (2015-2020)
12 Global Biopharmaceutical Contract Manufacturing Market Size Forecast (2021-2025)
12.1 Global Biopharmaceutical Contract Manufacturing Market Size Forecast (2021-2025)
12.2 Global Biopharmaceutical Contract Manufacturing Market Forecast by Regions (2021-2025)
12.3 North America Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2021-2025)
12.4 Europe Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2021-2025)
12.6 South America Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biopharmaceutical Contract Manufacturing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biopharmaceutical Contract Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biopharmaceutical Contract Manufacturing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biopharmaceutical Contract Manufacturing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Lonza Group Corporate Information, Location and Competitors
Table 6. Lonza Group Biopharmaceutical Contract Manufacturing Major Business
Table 7. Lonza Group Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 8. Lonza Group SWOT Analysis
Table 9. Lonza Group Biopharmaceutical Contract Manufacturing Product and Solutions
Table 10. Lonza Group Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Biomeva Corporate Information, Location and Competitors
Table 12. Biomeva Biopharmaceutical Contract Manufacturing Major Business
Table 13. Biomeva Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2018-2019)
Table 14. Biomeva SWOT Analysis
Table 15. Biomeva Biopharmaceutical Contract Manufacturing Product and Solutions
Table 16. Biomeva Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Fujifilm Diosynth Biotechnologies Corporate Information, Location and Competitors
Table 18. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Major Business
Table 19. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 20. Fujifilm Diosynth Biotechnologies SWOT Analysis
Table 21. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Product and Solutions
Table 22. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Baxter Biopharma Solutions Corporate Information, Location and Competitors
Table 24. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Major Business
Table 25. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 26. Baxter Biopharma Solutions SWOT Analysis
Table 27. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Product and Solutions
Table 28. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Rentschler Biotechnologie Corporate Information, Location and Competitors
Table 30. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Major Business
Table 31. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 32. Rentschler Biotechnologie SWOT Analysis
Table 33. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Product and Solutions
Table 34. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Samsung Corporate Information, Location and Competitors
Table 36. Samsung Biopharmaceutical Contract Manufacturing Major Business
Table 37. Samsung Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 38. Samsung SWOT Analysis
Table 39. Samsung Biopharmaceutical Contract Manufacturing Product and Solutions
Table 40. Samsung Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Cytovance Biologics Corporate Information, Location and Competitors
Table 42. Cytovance Biologics Biopharmaceutical Contract Manufacturing Major Business
Table 43. Cytovance Biologics Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 44. Cytovance Biologics SWOT Analysis
Table 45. Cytovance Biologics Biopharmaceutical Contract Manufacturing Product and Solutions
Table 46. Cytovance Biologics Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Patheon Corporate Information, Location and Competitors
Table 48. Patheon Biopharmaceutical Contract Manufacturing Major Business
Table 49. Patheon Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 50. Patheon SWOT Analysis
Table 51. Patheon Biopharmaceutical Contract Manufacturing Product and Solutions
Table 52. Patheon Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 54. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Major Business
Table 55. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 56. Boehringer Ingelheim SWOT Analysis
Table 57. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Product and Solutions
Table 58. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Probiogen Corporate Information, Location and Competitors
Table 60. Probiogen Biopharmaceutical Contract Manufacturing Major Business
Table 61. Probiogen Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 62. Probiogen SWOT Analysis
Table 63. Probiogen Biopharmaceutical Contract Manufacturing Product and Solutions
Table 64. Probiogen Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. KBI Biopharma Corporate Information, Location and Competitors
Table 66. KBI Biopharma Biopharmaceutical Contract Manufacturing Major Business
Table 67. KBI Biopharma Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 68. KBI Biopharma SWOT Analysis
Table 69. KBI Biopharma Biopharmaceutical Contract Manufacturing Product and Solutions
Table 70. KBI Biopharma Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. WuXi Biologics Corporate Information, Location and Competitors
Table 72. WuXi Biologics Biopharmaceutical Contract Manufacturing Major Business
Table 73. WuXi Biologics Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 74. WuXi Biologics SWOT Analysis
Table 75. WuXi Biologics Biopharmaceutical Contract Manufacturing Product and Solutions
Table 76. WuXi Biologics Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Abzena Corporate Information, Location and Competitors
Table 78. Abzena Biopharmaceutical Contract Manufacturing Major Business
Table 79. Abzena Biopharmaceutical Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 80. Abzena SWOT Analysis
Table 81. Abzena Biopharmaceutical Contract Manufacturing Product and Solutions
Table 82. Abzena Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Biopharmaceutical Contract Manufacturing Revenue (Million USD) by Players (2015-2020)
Table 84. Global Biopharmaceutical Contract Manufacturing Revenue Share by Players (2015-2020)
Table 85. Global Biopharmaceutical Contract Manufacturing Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Regions (2015-2020)
Table 87. North America Biopharmaceutical Contract Manufacturing Revenue by Countries (2015-2020)
Table 88. North America Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Table 89. Europe Biopharmaceutical Contract Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Biopharmaceutical Contract Manufacturing Revenue by Countries (2015-2020)
Table 92. South America Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Table 95. Global Biopharmaceutical Contract Manufacturing Revenue (Million USD) by Type (2015-2020)
Table 96. Global Biopharmaceutical Contract Manufacturing Revenue Share by Type (2015-2020)
Table 97. Global Biopharmaceutical Contract Manufacturing Revenue Forecast by Type (2021-2025)
Table 98. Global Biopharmaceutical Contract Manufacturing Revenue by Application (2015-2020)
Table 99. Global Biopharmaceutical Contract Manufacturing Revenue Share by Application (2015-2020)
Table 100. Global Biopharmaceutical Contract Manufacturing Revenue Forecast by Application (2021-2025)
Table 101. Global Biopharmaceutical Contract Manufacturing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biopharmaceutical Contract Manufacturing Picture
Figure 2. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type in 2019
Figure 3. Growth Factors Picture
Figure 4. Interferons Picture
Figure 5. Monoclonal Antibodies Picture
Figure 6. Recombinant Hormones Picture
Figure 7. Vaccines Picture
Figure 8. Insulin Picture
Figure 9. Others Picture
Figure 10. Biopharmaceutical Contract Manufacturing Revenue Market Share by Application in 2019
Figure 11. Autoimmune Diseases Picture
Figure 12. Oncology Picture
Figure 13. Metabolic Diseases Picture
Figure 14. Ophthalmology Picture
Figure 15. Cardiovascular Diseases Picture
Figure 16. Infectious Diseases Picture
Figure 17. Neurology Picture
Figure 18. Respiratory Disorders Picture
Figure 19. Others Picture
Figure 20. Global Biopharmaceutical Contract Manufacturing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 21. North America Biopharmaceutical Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Europe Biopharmaceutical Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. South America Biopharmaceutical Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 26. Global Biopharmaceutical Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 27. Global Biopharmaceutical Contract Manufacturing Revenue Share by Players in 2019
Figure 28. Global Top 5 Players Biopharmaceutical Contract Manufacturing Revenue Market Share in 2019
Figure 29. Global Top 10 Players Biopharmaceutical Contract Manufacturing Revenue Market Share in 2019
Figure 30. Key Players Market Share Trend
Figure 31. Global Biopharmaceutical Contract Manufacturing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 32. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Regions (2015-2020)
Figure 33. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Regions in 2018
Figure 34. North America Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 35. Europe Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 36. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 37. South America Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 38. Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 39. North America Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 40. North America Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries in 2019
Figure 41. USA Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 42. Canada Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 43. Mexico Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 44. Europe Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 45. Europe Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries in 2019
Figure 46. Germany Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 47. UK Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 48. France Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 49. Russia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 50. Italy Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 51. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 52. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries in 2019
Figure 53. China Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 54. Japan Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 55. Korea Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 56. India Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 57. Southeast Asia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 58. South America Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 59. South America Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries in 2019
Figure 60. Brazil Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 61. Argentina Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 62. Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 63. Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue Market Share by Countries in 2019
Figure 64. Saudi Arabia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 65. UAE Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 66. Egypt Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 67. South Africa Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 68. Global Biopharmaceutical Contract Manufacturing Revenue Share by Type (2015-2020)
Figure 69. Global Biopharmaceutical Contract Manufacturing Revenue Share by Type in 2019
Figure 70. Global Biopharmaceutical Contract Manufacturing Market Share Forecast by Type (2021-2025)
Figure 71. Global Growth Factors Revenue Growth Rate (2015-2020)
Figure 72. Global Interferons Revenue Growth Rate (2015-2020)
Figure 73. Global Monoclonal Antibodies Revenue Growth Rate (2015-2020)
Figure 74. Global Recombinant Hormones Revenue Growth Rate (2015-2020)
Figure 75. Global Vaccines Revenue Growth Rate (2015-2020)
Figure 76. Global Insulin Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global Biopharmaceutical Contract Manufacturing Revenue Share by Application (2015-2020)
Figure 79. Global Biopharmaceutical Contract Manufacturing Revenue Share by Application in 2019
Figure 80. Global Biopharmaceutical Contract Manufacturing Market Share Forecast by Application (2021-2025)
Figure 81. Global Autoimmune Diseases Revenue Growth Rate (2015-2020)
Figure 82. Global Oncology Revenue Growth Rate (2015-2020)
Figure 83. Global Metabolic Diseases Revenue Growth Rate (2015-2020)
Figure 84. Global Ophthalmology Revenue Growth Rate (2015-2020)
Figure 85. Global Cardiovascular Diseases Revenue Growth Rate (2015-2020)
Figure 86. Global Infectious Diseases Revenue Growth Rate (2015-2020)
Figure 87. Global Neurology Revenue Growth Rate (2015-2020)
Figure 88. Global Respiratory Disorders Revenue Growth Rate (2015-2020)
Figure 89. Global Others Revenue Growth Rate (2015-2020)
Figure 90. Global Biopharmaceutical Contract Manufacturing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 91. Global Biopharmaceutical Contract Manufacturing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 92. Global Biopharmaceutical Contract Manufacturing Revenue Market Share Forecast by Regions (2021-2025)
Figure 93. North America Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2021-2025)
Figure 94. Europe Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2021-2025)
Figure 95. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2021-2025)
Figure 96. South America Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2021-2025)
Figure 97. Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue Market Forecast (2021-2025)
Figure 98. Sales Channel: Direct Channel vs Indirect Channel
バイオ医薬品受託製造（BCMO）の世界市場（～2026年） Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing Market The global Biopharmaceutical Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Biopharmaceutical Contract Manufa…- バイオ医薬品発酵システムの世界市場（～2026年） Biopharmaceutical fermentation system refers to a biopharmaceutical equipment, it can be divided into fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation. In terms of application, the recombinant proteins segment held a major market share in 2017. High reliance …
- バイオ医薬品の世界市場（～2026年） A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood compon…
- 医薬品受託製造・受託の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Pharmaceutical Contract Manufacturing and Contract market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market playe…
- 契約バイオマニュファクチャリングサービスの世界市場（～2026年） Market Analysis and Insights: Global Contract Biomanufacturing Services Market The global Contract Biomanufacturing Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Contract Biomanufacturing Services Scope and …